tag Clinical Development Related Topics 
Drug Discovery World
DECEMBER 20, 2022
The clinical development of etranacogene dezaparvovec was led by uniQure and sponsorship of the clinical trials transitioned to CSL after it licensed global rights to commercialise the treatment. . Following infusion of etranacogene dezaparvovec, 96% of patients discontinued routine FIX prophylaxis. .
pharmaphorum
JANUARY 24, 2022
Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
DECEMBER 3, 2020
Based on the positive Phase 1 results reported and the unprecedented need for COVID-19 vaccines, Clover and its partners are confident to enter late-stage clinical development for both adjuvanted vaccines. The Phase 1 clinical trial was funded by the Coalition for Epidemic Preparedness Innovations (CEPI).
The Pharma Data
JANUARY 31, 2021
These findings give confidence that Clover’s COVID-19 vaccine candidates are suitable for further clinical development.” Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology.
pharmaphorum
DECEMBER 23, 2022
There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. As inobrodib also has an effect on the androgen receptor pathway, with potential in prostate cancer, also.
pharmaphorum
NOVEMBER 19, 2020
Because Roche has never applied for Avastin to be used in wet AMD, clinics in the US have had to choose between the peace of mind offered by the regulatory process and Lucentis’ higher price tag, or the unapproved off-label formulation of Avastin at a lower price.
pharmaphorum
JANUARY 11, 2021
million price tag. On the oncology side, bluebird has also strengthened its board with the appointment of Dr Ramy Ibrahim, a high-profile leader in clinical development in immunotherapy and cell therapy. Zynteglo is already in beta-thalassemia in Europe, where the company will seek to expand access despite its hefty $1.8
Expert insights. Personalized for you.
52 
Let's personalize your content